These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10958077)

  • 1. Modulation of intravenous cocaine effects by chronic oral cocaine in humans.
    Walsh SL; Haberny KA; Bigelow GE
    Psychopharmacology (Berl); 2000 Jul; 150(4):361-73. PubMed ID: 10958077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration of the D1/5 antagonist ecopipam fails to attenuate the subjective effects of cocaine.
    Nann-Vernotica E; Donny EC; Bigelow GE; Walsh SL
    Psychopharmacology (Berl); 2001 Jun; 155(4):338-47. PubMed ID: 11441423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study.
    Pirtle JL; Hickman MD; Boinpelly VC; Surineni K; Thakur HK; Grasing KW
    Pharmacol Biochem Behav; 2019 May; 180():52-59. PubMed ID: 30811963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans.
    Evans SM; Walsh SL; Levin FR; Foltin RW; Fischman MW; Bigelow GE
    Drug Alcohol Depend; 2001 Nov; 64(3):271-83. PubMed ID: 11672942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans.
    Smith BJ; Jones HE; Griffiths RR
    Psychopharmacology (Berl); 2001 Aug; 156(4):435-44. PubMed ID: 11498721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine effects during D-amphetamine maintenance: a human laboratory analysis of safety, tolerability and efficacy.
    Rush CR; Stoops WW; Hays LR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):261-71. PubMed ID: 18926645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of oral cocaine on intravenous cocaine discrimination in humans.
    Johanson CE; Lundahl LH; Schubiner H
    Exp Clin Psychopharmacol; 2007 Jun; 15(3):219-27. PubMed ID: 17563208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute physiological and behavioral effects of oral cocaine in humans: a dose-response analysis.
    Rush CR; Baker RW; Wright K
    Drug Alcohol Depend; 1999 Jun; 55(1-2):1-12. PubMed ID: 10402144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smoked cocaine self-administration is decreased by modafinil.
    Hart CL; Haney M; Vosburg SK; Rubin E; Foltin RW
    Neuropsychopharmacology; 2008 Mar; 33(4):761-8. PubMed ID: 17568397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans.
    Walsh SL; Geter-Douglas B; Strain EC; Bigelow GE
    J Pharmacol Exp Ther; 2001 Oct; 299(1):147-58. PubMed ID: 11561074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of cocaine self-administration by chronic oral phendimetrazine in rhesus monkeys.
    Czoty PW; Blough BE; Fennell TR; Snyder RW; Nader MA
    Neuroscience; 2016 Jun; 324():367-76. PubMed ID: 26964683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoxetine alters the effects of intravenous cocaine in humans.
    Walsh SL; Preston KL; Sullivan JT; Fromme R; Bigelow GE
    J Clin Psychopharmacol; 1994 Dec; 14(6):396-407. PubMed ID: 7884020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals.
    Grasing K; Mathur D; Newton TF; DeSouza C
    Drug Alcohol Depend; 2010 Feb; 107(1):69-75. PubMed ID: 19836169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic d-amphetamine administration on the reinforcing strength of cocaine in rhesus monkeys.
    Czoty PW; Martelle JL; Nader MA
    Psychopharmacology (Berl); 2010 May; 209(4):375-82. PubMed ID: 20217052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of repeated-dose isradipine on the abuse liability of cocaine.
    Roache JD; Johnson BA; Ait-Daoud N; Mauldin JB; Thornton JE; Wells LT; Murff WL
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):319-26. PubMed ID: 16366762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cocaine and metabolite concentrations in plasma during repeated oral administration: development of a human laboratory model of chronic cocaine use.
    Jufer RA; Walsh SL; Cone EJ
    J Anal Toxicol; 1998 Oct; 22(6):435-44. PubMed ID: 9788518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A paradigm to investigate the regulation of cocaine self-administration in human cocaine users: a randomized trial.
    Lynch WJ; Sughondhabirom A; Pittman B; Gueorguieva R; Kalayasiri R; Joshua D; Morgan P; Coric V; Malison RT
    Psychopharmacology (Berl); 2006 Apr; 185(3):306-14. PubMed ID: 16521032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclazocine: comparison to hydromorphone and interaction with cocaine.
    Preston KL; Umbricht A; Schroeder JR; Abreu ME; Epstein DH; Pickworth WB
    Behav Pharmacol; 2004 Mar; 15(2):91-102. PubMed ID: 15096909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of baclofen on cocaine self-administration: opioid- and nonopioid-dependent volunteers.
    Haney M; Hart CL; Foltin RW
    Neuropsychopharmacology; 2006 Aug; 31(8):1814-21. PubMed ID: 16407903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reinforcing effects of oral cocaine: contextual determinants.
    Jones HE; Garrett BE; Griffiths RR
    Psychopharmacology (Berl); 2001 Mar; 154(2):143-52. PubMed ID: 11314676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.